|
|
|
|
Document Preview Agreement and Plan of Merger |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Agreement and Plan of Merger |
|||
|
Entities: |
||||
|
Date: |
2007 |
|||
|
Size: |
247KB total |
|||
|
Price: |
$79 |
|||
|
ID: |
#2712467 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
KYPHON INC.
NEPTUNE ACQUISITION SUB, INC.
AND
ST. FRANCIS MEDICAL TECHNOLOGIES, INC.
AND WITH RESPECT TO ARTICLE VII ONLY
PHILIP M. YOUNG
AS STOCKHOLDERS REPRESENTATIVE
Dated as of December 4, 2006
TABLE OF CONTENTS
| Page | ||||
|
ARTICLE I. THE MERGER |
1 | |||
|
1.1 |
The Merger | 1 | ||
|
1.2 |
Effective Time; Closing | 1 | ||
|
1.3 |
Effect of the Merger | 2 | ||
|
1.4 |
Certificate of Incorporation and Bylaws | 2 | ||
|
1.5 |
Directors and Officers | 2 | ||
|
1.6 |
Effect on Capital Stock | 2 | ||
|
1.7 |
Additional Merger Consideration | 4 | ||
|
1.8 |
Surrender of Certificates | 8 | ||
|
1.9 |
No Further Ownership Rights in Company Capital Stock | 10 | ||
|
1.10 |
Lost, Stolen or Destroyed Certificates | 10 | ||
|
1.11 |
Further Action | 11 | ||
|
ARTICLE II. REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
11 | |||
|
2.1 |
Organization; Standing and Power; Charter Documents; Subsidiaries | 11 | ||
|
2.2 |
Capital Structure | 12 | ||
|
2.3 |
Authority; Non-Contravention; Necessary Consents | 14 | ||
|
2.4 |
Financial Statements | 15 | ||
|
2.5 |
Corporate Governance | 16 | ||
|
2.6 |
Undisclosed Liabilities | 16 | ||
|
2.7 |
Absence of Certain Changes or Events | 17 | ||
|
2.8 |
Taxes | 17 | ||
|
2.9 |
Intellectual Property | 20 | ||
|
2.10 |
Compliance; Permits | 24 | ||
|
2.11 |
Litigation | 25 | ||
|
2.12 |
Brokers and Finders Fees; Fees and Expenses | 25 | ||
|
2.13 |
Employee Benefit Plans | 25 | ||
|
2.14 |
Real Property | 29 | ||
|
2.15 |
Assets | 29 | ||
|
2.16 |
Environmental Matters | 29 | ||
|
2.17 |
Contracts | 30 | ||
|
2.18 |
Regulatory Compliance | 32 | ||
|
2.19 |
Health Care Compliance | 33 | ||
|
2.20 |
Insurance | 34 | ||
|
2.21 |
Interested Party Transactions | 34 | ||
|
2.22 |
Customers and Suppliers | 35 | ||
|
ARTICLE III. REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB |
35 | |||
-i-
TABLE OF CONTENTS
(Continued)
| Page | ||||
|
3.1 |
Organization; Standing and Power; Charter Documents; Subsidiaries | 35 | ||
|
3.2 |
Merger Sub | 36 | ||
|
3.3 |
Authority; Non-Contravention; Necessary Consents | 36 | ||
|
3.4 |
Compliance; Permits | 37 | ||
|
3.5 |
Litigation | 37 | ||
|
3.6 |
SEC Filings; Financial Statements | 37 | ||
|
3.7 |
Absence of Certain Changes or Events | 39 | ||
|
3.8 |
Intellectual Property | 39 | ||
|
3.9 |
Availability of Funds | 40 | ||
|
ARTICLE IV. CONDUCT BY THE COMPANY PRIOR TO THE EFFECTIVE TIME |
41 | |||
|
4.1 |
Conduct of Business by the Company | 41 | ||
|
ARTICLE V. ADDITIONAL AGREEMENTS |
44 | |||
|
5.1 |
Acquisition Proposals | 44 | ||
|
5.2 |
Information Statement | 45 | ||
|
5.3 |
Stockholder Approval | 45 | ||
|
5.4 |
Confidentiality; Access to Information; No Modification of Representations, Warranties or Covenants | 45 | ||
|
5.5 |
Public Disclosure | 46 | ||
|
5.6 |
Regulatory Filings; Reasonable Best Efforts | 46 | ||
|
5.7 |
Employee Benefits | 48 | ||
|
5.8 |
Indemnification | 51 | ||
|
5.9 |
Certain Tax Matters | 52 | ||
|
5.10 |
Third Party Consents | 54 | ||
|
5.11 |
Merger Sub Compliance | 54 | ||
|
5.12 |
Termination of Credit Facility | 55 | ||
|
ARTICLE VI. CONDITIONS TO THE MERGER |
55 | |||
|
6.1 |
Conditions to the Obligations of Each Party to Effect the Merger | 55 | ||
|
6.2 |
Additional Conditions to the Obligations of the Company | 55 | ||
|
6.3 |
Additional Conditions to the Obligations of Parent and Merger Sub | 56 | ||
|
ARTICLE VII. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ESCROW |
57 | |||
|
7.1 |
Definitions | 57 | ||
|
7.2 |
Survival of Representations and Warranties | 59 | ||
|
7.3 |
Representative Reimbursement Amount Deposit | 59 | ||
|
7.4 |
Set-Off From Earnout Amount | 59 | ||
-ii-
TABLE OF CONTENTS
(Continued)
| Page | ||||
|
7.5 |
Exclusive Remedy | 61 | ||
|
7.6 |
Distribution of Earnout Amount | 61 | ||
|
7.7 |
Stockholders Representative | 62 | ||
|
7.8 |
Third-Party Claims | 63 | ||
|
7.9 |
No Other Representations and Warranties | 64 | ||
|
7.10 |
Resolution of Claims | 65 | ||
|
ARTICLE VIII. TERMINATION, AMENDMENT AND WAIVER |
65 | |||
|
8.1 |
Termination | 65 | ||
|
8.2 |
Notice of Termination; Effect of Termination | 66 | ||
|
8.3 |
Fees and Expenses | 67 | ||
|
8.4 |
Amendment | 67 | ||
|
8.5 |
Extension; Waiver | 67 | ||
|
ARTICLE IX. GENERAL PROVISIONS |
67 | |||
|
9.1 |
Notices | 67 | ||
|
9.2 |
Interpretation; Knowledge | 68 | ||
|
9.3 |
Counterparts | 70 | ||
|
9.4 |
Entire Agreement; Third-Party Beneficiaries | 70 | ||
|
9.5 |
Severability | 70 | ||
|
9.6 |
Other Remedies | 70 | ||
|
9.7 |
Governing Law | 70 | ||
|
9.8 |
Consent to Jurisdiction | 71 | ||
|
9.9 |
Rules of Construction | 71 | ||
|
9.10 |
Assignment | 71 | ||
|
9.11 |
No Waiver | 71 | ||
-iii-
Exhibits
|
Exhibit A |
Form of Management Escrow Agreement | |
|
Exhibit B |
Form of Closing Certificate | |
|
Exhibit C |
Form of Parachute Payment Waiver | |
|
Exhibit D |
Form of Legal Opinion |
-iv-
Index of Defined Terms
|
Term |
Section | |
|
Acquisition Proposal |
5.1(a) | |
|
Action |
7.1 | |
|
Action of Divestiture |
5.6(e) | |
|
Affiliate |
9.2(b) | |
|
Agreement |
Preamble | |
|
Assets |
2.15 | |
|
Cash Payment Right |
1.6(d) | |
|
Certificate of Merger |
1.2 | |
|
Certificates |
1.8(c) | |
|
Change of Control |
1.7(a) | |
|
Claim |
7.10(a) | |
|
Closing |
1.2 | |
|
Closing Certificate |
1.6(f) | |
|
Closing Date |
1.2 | |
|
Closing Expenses |
7.1 | |
|
Code |
1.8(d) | |
|
Company |
Preamble | |
|
Company Balance Sheet |
2.4 | |
|
Company Benefit Plans |
2.13(b)(i) | |
|
Company Board Recommendation |
2.3(a)(iv) | |
|
Company Business |
2.9(a)(i) | |
|
Company Capital Stock |
1.6(a) | |
|
Company Charter Documents |
2.1(b) | |
|
Company Common Stock |
1.6(a) | |
|
Company Disclosure Letter |
Article II Preamble | |
|
Company Indemnified Liabilities |
5.8(a) | |
|
Company Indemnified Parties |
5.8(a) | |
|
Company Indemnified Proceedings |
5.8(a) | |
|
Company Intellectual Property |
2.9(a)(v) | |
|
Company IP Contract |
2.9(a)(ii) | |
-v-
|
Term |
Section | |
|
Company Material Contract |
2.17(a) | |
|
Company Option |
1.6(d) | |
|
Company Option Plan |
1.6(d) | |
|
Company Participants |
5.7(a) | |
|
Company Permits |
2.10(b) | |
|
Company Preferred Stock |
2.2(a)(ii) | |
|
Company Products |
2.9(a)(iii) | |
|
Company Registered Intellectual Property |
2.9(a)(vi) | |
|
Company Restricted Stock |
5.7(f)(ii) | |
|
Company Stockholder |
7.1 | |
|
Confidentiality Agreement |
5.4(a) | |
|
Contract |
2.2(a) | |
|
Credit Facility |
5.12 | |
|
D&O Insurance |
5.8(c) | |
|
Deductible Amount |
7.4(b) | |
|
Deferred Payments |
1.7(b)(i) | |
|
Delaware Law |
Recitals | |
|
DGCL |
1.6(c)(i) | |
|
Disputed Items |
1.7(c)(ii) | |
|
Dispute Notice |
1.7(c)(ii) | |
|
Dissenting Shares |
1.6(c)(i) | |
|
DOJ |
5.6(a)(i) | |
|
Earnout Amount |
1.7(a) | |
|
Earnout Revenue |
1.7(a) | |
|
Earnout Statement |
1.7(c)(i) | |
|
Effective Time |
1.2 | |
|
Employee |
2.13(a)(ii) | |
|
End Date |
8.1(c) | |
|
Environmental Laws |
2.16(i) | |
|
ERISA |
2.13(b)(i) | |
|
ERISA Affiliate |
2.13(b)(i) | |
-vi-
|
Term |
Section | |
|
Exchange Agent |
1.8(a) | |
|
Exchange Fund |
1.8(b) | |
|
FDA |
2.18(a) | |
|
Final Deferred Payment |
1.7(b)(i)(2) | |
|
Financial Statements |
2.4 | |
|
Financing |
3.9 | |
|
Financing Commitment |
3.9 | |
|
First Deferred Payment Date |
1.7(a) | |
|
First Earnout Amount |
1.7(a) | |
|
First Earnout Revenue |
1.7(a) | |
|
FTC |
5.6(a)(i) | |
|
GAAP |
2.4 | |
|
Governmental Consents |
6.1(b) | |
|
Governmental Entity |
2.3(c) | |
|
Hazardous Materials |
2.16(a)(ii) | |
|
Health Care Laws |
2.19(b) | |
|
HSR Act |
2.3(c) | |
|
Indemnification Termination Date |
7.1 | |
|
Indemnified Parties |
7.1 | |
|
Information Statement |
5.2 | |
|
Initial Deferred Payment |
1.7(b)(i)(1) | |
|
Intellectual Property |
2.9(a)(iv) | |
|
International Employee Plan |
2.13(g) | |
|
IPD Devices |
1.7(a) | |
|
IRS |
7.1 | |
|
Knowledge |
9.2(c) | |
|
Leased Real Property |
2.14 | |
|
Leases |
2.14 | |
|
Legal Proceedings |
2.11 | |
|
Legal Requirements |
2.2(d) | |
|
Lender |
3.9 | |
-vii-
|
Term |
Section | |
|
Liens |
2.1(c) | |
|
Losses |
7.1 | |
|
Management Escrow Agreement |
1.6(d) | |
|
Management Shares |
5.7(f)(ii) | |
|
Material Adverse Effect |
9.2(d) | |
|
Merger |
1.1 | |
|
Merger Consideration |
7.1 | |
|
Merger Sub |
Preamble | |
|
Necessary Consents |
2.3(c) | |
|
Neutral Arbitrator |
1.7(c)(iii) | |
|
Objection Notice |
7.10(a) | |
|
Officers Certificate |
7.1 | |
|
Option Shares |
1.6(d) | |
|
Outstanding Shares |
7.1 | |
|
Parachute Payment Waiver |
5.10(f) | |
|
Parent |
Preamble | |
|
Parent Balance Sheet |
3.6(b) | |
|
Parent Disclosure Letter |
Article III Preamble | |
|
Parent ESPP |
5.7(b) | |
|
Parent Financials |
3.6(b) | |
|
Parent Permits |
3.4(b) | |
|
Parent SEC Reports |
3.6(a) | |
|
Per Share Consideration |
7.1 | |
|
Per Share Earnout Amount |
1.7(a) | |
|
Permits |
2.10(b) | |
|
Person |
9.2(e) | |
|
Post-Closing Tax Period |
7.1 | |
|
Pre-Closing Tax Period |
7.1 | |
|
Pro Rata Portion |
7.1 | |
|
Programs |
2.19(a) | |
|
Registered Intellectual Property |
2.9(a)(vii) | |
-viii-
|
Term |
Section | |
|
Representative Reimbursement Amount |
7.1 | |
|
Resolution Period |
1.7(c)(ii) | |
|
Revenue |
1.7(a) | |
|
Safety Notices |
2.18(h)(i) | |
|
Second Deferred Payment Date |
1.7(a) | |
|
Second Earnout Amount |
1.7(a) | |
|
Second Earnout Revenue |
1.7(a) | |
|
Series A Preferred Stock |
1.6(a) | |
|
Series B Preferred Stock |
1.6(a) | |
|
Series C Preferred Stock |
1.6(a) | |
|
Significant Customer |
2.22(a) | |
|
Significant Supplier |
2.22(b) | |
|
Specified Persons |
1.7(a) | |
|
Stockholder Approval |
Recitals | |
|
Stockholders Representative |
7.7(a) | |
|
Stockholders Representative Expenses |
7.7(b) | |
|
Straddle Period |
7.1 | |
|
Subsidiary |
2.1(a) | |
|
Subsidiary Charter Documents |
2.1(b) | |
|
Surviving Corporation |
1.1 | |
|
Tax |
2.8(a) | |
|
Taxes |
2.8(a) | |
|
Tax Claim |
5.9(c) | |
|
Tax Period |
7.1 | |
|
Tax Returns |
2.8(b)(i) | |
|
Third Party Claim |
7.8 | |
|
Threshold Amount |
7.4(b) | |
|
Transaction Costs |
8.3 | |
|
Transfer Taxes |
5.10(d) | |
|
Treasury Regulations |
2.8(b)(vii) | |
-ix-
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (this Agreement) is made and entered into as of December 4, 2006, by and among Kyphon Inc., a Delaware corporation (Parent), Neptune Acquisition Sub, Inc., a Delaware corporation and direct wholly-owned subsidiary of Parent (Merger Sub), and St. Francis Medical Technologies, Inc., a Delaware corporation (the Company), and with respect to Article VII only, Philip M. Young, as Stockholders Representative.
RECITALS
A. The respective Boards of Directors of Parent, Merger Sub and the Company have deemed it advisable and in the best interests of their respective corporations and stockholders that Parent and the Company consummate the business combination and other transactions provided for herein in order to advance their respective long-term strategic business interests.
B. The respective Boards of Directors of Parent, Merger Sub and the Company have approved, in accordance with applicable provisions of the laws of the State of Delaware (Delaware Law), this Agreement and the transactions contemplated hereby, including the Merger (as defined in Section 1.1).
C. Promptly following the execution and delivery of this Agreement, stockholders of the Company representing the requisite number of shares of each class of the Companys capital stock will, through an action by written consent (the Stockholder Approval), adopt this Agreement.
D. Parent, Merger Sub and the Company desire to make certain representations, warranties and agreements in connection with the Merger and also to prescribe certain conditions to the Merger.
NOW, THEREFORE, in consideration of the covenants, promises and representations set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
ARTICLE I.
THE MERGER
1.1 The Merger. At the Effective Time and subject to and upon the terms and conditions of this Agreement and the applicable provisions of Delaware Law, Merger Sub shall be merged with and into the Company (the Merger), the separate corporate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation. The Company, as the surviving corporation after the Merger, is hereinafter sometimes referred to as the Surviving Corporation.
1.2 Effective Time; Closing. Subject to the provisions of this Agreement, the parties hereto shall cause the Merger to be consummated by filing a Certificate of Merger with the Secretary of State of the State of Delaware in accordance
with the relevant provisions of Delaware Law (the Certificate of Merger) (the time of such filing with the Secretary of State of the State of Delaware (or such later time as may be agreed in writing by the Company and Parent and specified in the Certificate of Merger) being the Effective Time) as soon as practicable on or after the Closing Date (as defined below). The closing of the Merger (the Closing) shall take place at the offices of Wilson Sonsini Goodrich & Rosati, Professional Corporation, located at One Market, San Francisco, California, at a time and date to be specified by the parties, which shall be no later than the second business day after the satisfaction or waiver of the conditions set forth in Article VI (other than those that by their terms are to be satisfied or waived at the Closing), or at such other time, date and location as the parties hereto agree in writing. The date on which the Closing occurs is referred to herein as the Closing Date.
|
End of Preview |